ArticleFrontiers in immunology2026

Definitive chemoradiotherapy plus immune checkpoint inhibitors for locally advanced unresectable esophageal squamous cell carcinoma: survival and progression patterns in a propensity-matched cohort.

Zhongmei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.